Multidrug regimens for treatment of older patients with metastatic pancreatic cancer
Older patients with metastatic pancreatic adenocarcinoma (MPDAC) are under-represented in clinical trials.
Source: Digestive and Liver Disease - Category: Gastroenterology Authors: Marina Macchini, Marta Chiaravalli, Chiara Pircher, Silvia Zanon, Umberto Peretti, Elena Mazza, Maria Maddalena Valente, Clara Fugazza, Luca Gianni, Michele Reni Tags: Oncology Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Clinical Trials | Gastroenterology | Liver | Liver Disease | Pancreas | Pancreatic Cancer | Urology & Nephrology